How to advocate for the inclusion of chronic kidney disease in a national noncommunicable chronic disease program - PubMed (original) (raw)
. 2014 Jun;85(6):1269-74.
doi: 10.1038/ki.2012.488. Epub 2013 Feb 13.
Affiliations
- PMID: 23407433
- DOI: 10.1038/ki.2012.488
Free article
How to advocate for the inclusion of chronic kidney disease in a national noncommunicable chronic disease program
Marcello Tonelli et al. Kidney Int. 2014 Jun.
Free article
Abstract
Many countries are developing or refining national strategies for noncommunicable chronic disease (NCD) prevention and control. Chronic kidney disease (CKD) is a cause and consequence of other NCDs; CKD acts as a risk multiplier for all four key NCDs as specified by the World Health Organization; CKD is associated with high health-care costs; CKD is readily identifiable; and treatment of CKD is cost-effective and improves outcomes. These observations argue in favor of including CKD in national NCD programs. The purpose of this article is to outline key steps in advocating for the inclusion of CKD in national NCD strategies.
Similar articles
- The contribution of chronic kidney disease to the global burden of major noncommunicable diseases.
Couser WG, Remuzzi G, Mendis S, Tonelli M. Couser WG, et al. Kidney Int. 2011 Dec;80(12):1258-70. doi: 10.1038/ki.2011.368. Epub 2011 Oct 12. Kidney Int. 2011. PMID: 21993585 - Effective CKD care in European countries: challenges and opportunities for health policy.
Bello AK, Levin A, Manns BJ, Feehally J, Drueke T, Faruque L, Hemmelgarn BR, Kernahan C, Mann J, Klarenbach S, Remuzzi G, Tonelli M; Kidney Health for Life Initiative. Bello AK, et al. Am J Kidney Dis. 2015 Jan;65(1):15-25. doi: 10.1053/j.ajkd.2014.07.033. Epub 2014 Nov 5. Am J Kidney Dis. 2015. PMID: 25455091 - Integration of Care in Management of CKD in Resource-Limited Settings.
Okpechi IG, Bello AK, Ameh OI, Swanepoel CR. Okpechi IG, et al. Semin Nephrol. 2017 May;37(3):260-272. doi: 10.1016/j.semnephrol.2017.02.006. Semin Nephrol. 2017. PMID: 28532555 Review. - State approaches to stem toll of chronic kidney disease.
Chianchiano D. Chianchiano D. Adv Chronic Kidney Dis. 2008 Apr;15(2):174-6. doi: 10.1053/j.ackd.2008.01.009. Adv Chronic Kidney Dis. 2008. PMID: 18334243 Review. - Prevention programs for chronic kidney disease in low-income countries.
Perico N, Remuzzi G. Perico N, et al. Intern Emerg Med. 2016 Apr;11(3):385-9. doi: 10.1007/s11739-016-1425-7. Epub 2016 Mar 16. Intern Emerg Med. 2016. PMID: 26983956 Review.
Cited by
- Infection-Induced Kidney Diseases.
Prasad N, Patel MR. Prasad N, et al. Front Med (Lausanne). 2018 Nov 28;5:327. doi: 10.3389/fmed.2018.00327. eCollection 2018. Front Med (Lausanne). 2018. PMID: 30555828 Free PMC article. Review. - Chronic kidney disease and the global NCDs agenda.
Neuen BL, Chadban SJ, Demaio AR, Johnson DW, Perkovic V. Neuen BL, et al. BMJ Glob Health. 2017 Jul 6;2(2):e000380. doi: 10.1136/bmjgh-2017-000380. eCollection 2017. BMJ Glob Health. 2017. PMID: 29225940 Free PMC article. No abstract available. - Incidence of chronic kidney disease hospitalisations and mortality in Espírito Santo between 1996 to 2017.
de Souza W, de Abreu LC, Silva LGD, Bezerra IMP. de Souza W, et al. PLoS One. 2019 Nov 7;14(11):e0224889. doi: 10.1371/journal.pone.0224889. eCollection 2019. PLoS One. 2019. PMID: 31697772 Free PMC article. - Cardiovascular and Renal Outcomes With Canagliflozin According to Baseline Kidney Function.
Neuen BL, Ohkuma T, Neal B, Matthews DR, de Zeeuw D, Mahaffey KW, Fulcher G, Desai M, Li Q, Deng H, Rosenthal N, Jardine MJ, Bakris G, Perkovic V. Neuen BL, et al. Circulation. 2018 Oct 9;138(15):1537-1550. doi: 10.1161/CIRCULATIONAHA.118.035901. Circulation. 2018. PMID: 29941478 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical